Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Predictors of survival in a Huntington's disease population from southern Italy.

Rinaldi C, Salvatore E, Giordano I, De Matteis S, Tucci T, Cinzia VR, Rossi F, Castaldo I, Morra VB, Di Maio L, Filla A, De Michele G.

Can J Neurol Sci. 2012 Jan;39(1):48-51.

PMID:
22384495
2.

Survival of Huntington's disease patients in Serbia: longer survival in female patients.

Pekmezovic T, Svetel M, Maric J, Dujmovic-Basuroski I, Dragasevic N, Keckarevic M, Romac S, Kostic VS.

Eur J Epidemiol. 2007;22(8):523-6. Epub 2007 Jul 25.

PMID:
17653603
3.

[Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].

Vojvodić N, Culjković B, Romac S, Stojković O, Sternić N, Sokić D, Kostić VS.

Srp Arh Celok Lek. 1998 Mar-Apr;126(3-4):77-82. Serbian.

PMID:
9863360
4.

The relationship between CAG repeat length and clinical progression in Huntington's disease.

Ravina B, Romer M, Constantinescu R, Biglan K, Brocht A, Kieburtz K, Shoulson I, McDermott MP.

Mov Disord. 2008 Jul 15;23(9):1223-7. doi: 10.1002/mds.21988.

PMID:
18512767
5.

Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000.

Creighton S, Almqvist EW, MacGregor D, Fernandez B, Hogg H, Beis J, Welch JP, Riddell C, Lokkesmoe R, Khalifa M, MacKenzie J, Sajoo A, Farrell S, Robert F, Shugar A, Summers A, Meschino W, Allingham-Hawkins D, Chiu T, Hunter A, Allanson J, Hare H, Schween J, Collins L, Sanders S, Greenberg C, Cardwell S, Lemire E, MacLeod P, Hayden MR.

Clin Genet. 2003 Jun;63(6):462-75.

PMID:
12786753
6.

Clinical and genetic characteristics of Mexican Huntington's disease patients.

Alonso ME, Ochoa A, Boll MC, Sosa AL, Yescas P, López M, Macias R, Familiar I, Rasmussen A.

Mov Disord. 2009 Oct 15;24(13):2012-5. doi: 10.1002/mds.22737.

PMID:
19672992
7.

Clinical and genetic characteristics in patients with Huntington's Disease from Argentina.

Gatto E, Parisi V, Persi G, Converso DP, Etcheverry JL, Varela V, Lopez A, Alba L, Fretchel G.

Parkinsonism Relat Disord. 2012 Feb;18(2):166-9. doi: 10.1016/j.parkreldis.2011.09.011. Epub 2011 Oct 1. Erratum in: Parkinsonism Relat Disord. 2014 Jan;20(1):136. Lopez, Ariel [added].

PMID:
21962718
8.

A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease.

Dhaenens CM, Burnouf S, Simonin C, Van Brussel E, Duhamel A, Defebvre L, Duru C, Vuillaume I, Cazeneuve C, Charles P, Maison P, Debruxelles S, Verny C, Gervais H, Azulay JP, Tranchant C, Bachoud-Levi AC, Dürr A, Buée L, Krystkowiak P, Sablonnière B, Blum D; Huntington French Speaking Network.

Neurobiol Dis. 2009 Sep;35(3):474-6. doi: 10.1016/j.nbd.2009.06.009. Epub 2009 Jul 8.

PMID:
19591938
9.

Family and molecular data for a fine analysis of age at onset in Huntington disease.

Squitieri F, Sabbadini G, Mandich P, Gellera C, Di Maria E, Bellone E, Castellotti B, Nargi E, de Grazia U, Frontali M, Novelletto A.

Am J Med Genet. 2000 Dec 11;95(4):366-73.

PMID:
11186892
10.

Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.

Paulsen JS, Long JD, Ross CA, Harrington DL, Erwin CJ, Williams JK, Westervelt HJ, Johnson HJ, Aylward EH, Zhang Y, Bockholt HJ, Barker RA; PREDICT-HD Investigators and Coordinators of the Huntington Study Group.

Lancet Neurol. 2014 Dec;13(12):1193-201. doi: 10.1016/S1474-4422(14)70238-8. Epub 2014 Nov 3.

11.

The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease.

Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S, Starr E, Squitieri F, Lin B, Kalchman MA, et al.

Nat Genet. 1993 Aug;4(4):398-403.

PMID:
8401589
12.

CAG/CTG repeat expansions at the Huntington's disease-like 2 locus are rare in Huntington's disease patients.

Stevanin G, Camuzat A, Holmes SE, Julien C, Sahloul R, Dodé C, Hahn-Barma V, Ross CA, Margolis RL, Durr A, Brice A.

Neurology. 2002 Mar 26;58(6):965-7.

PMID:
11914418
13.

Age at onset in Huntington's disease: replication study on the association of HAP1.

Karadima G, Dimovasili C, Koutsis G, Vassilopoulos D, Panas M.

Parkinsonism Relat Disord. 2012 Nov;18(9):1027-8. doi: 10.1016/j.parkreldis.2012.05.020. Epub 2012 Jun 12.

PMID:
22698993
14.

Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects : a cross-sectional study.

Klepac N, Relja M, Klepac R, Hećimović S, Babić T, Trkulja V.

J Neurol. 2007 Dec;254(12):1676-83. Epub 2007 Nov 9.

PMID:
17990062
15.

Incidence and mutation rates of Huntington's disease in Spain: experience of 9 years of direct genetic testing.

Ramos-Arroyo MA, Moreno S, Valiente A.

J Neurol Neurosurg Psychiatry. 2005 Mar;76(3):337-42.

16.

CAG repeat number governs the development rate of pathology in Huntington's disease.

Penney JB Jr, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH.

Ann Neurol. 1997 May;41(5):689-92.

PMID:
9153534
17.

[Huntington's disease mortality in Spain in the period 1981-2004].

Ramalle-Gomara E, Gonzalez MA, Perucha M, Quinones C, Lezaun ME, Posada-De la Paz M.

Rev Neurol. 2007 Jul 16-31;45(2):88-90. Spanish.

18.

Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.

Ruocco HH, Bonilha L, Li LM, Lopes-Cendes I, Cendes F.

J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):130-5. Epub 2007 Jul 5.

PMID:
17615168
19.

Correlations between triplet repeat expansion and clinical features in Huntington's disease.

Claes S, Van Zand K, Legius E, Dom R, Malfroid M, Baro F, Godderis J, Cassiman JJ.

Arch Neurol. 1995 Aug;52(8):749-53.

PMID:
7639626
20.

A study of the Huntington's disease associated trinucleotide repeat in the Scottish population.

Barron LH, Warner JP, Porteous M, Holloway S, Simpson S, Davidson R, Brock DJ.

J Med Genet. 1993 Dec;30(12):1003-7.

Supplemental Content

Support Center